The Potential Role of Creatine Supplementation in Neurodegenerative Diseases

Overview

Journal Phys Act Nutr

Date 2024 Feb 1

PMID 38297476

Authors

Hyukki Chang

Yea-Hyun Leem

Affiliations

Soon will be listed here.

Abstract

Purpose: The maintenance of energy balance in the body, especially in energy-demanding tissues like the muscles and the central nervous system, depends on creatine (Cr). In addition to improving muscle function, Cr is necessary for the bioenergetics of the central nervous system because it replenishes adenosine triphosphate without needing oxygen. Furthermore, Cr possesses anti-oxidant, anti-apoptotic, and anti-excitotoxic properties. Clinical research on neurodegenerative illnesses has shown that Cr supplementation results in less effective outcomes. With a brief update on the possible role of Cr in human, animal, and in vitro experiments, this review seeks to offer insights into the ideal dosage regimen.

Methods: Using specified search phrases, such as "creatine and neurological disorder," "creatine supplementation and neurodegenerative disorders," and "creatine and brain," we searched articles in the PubMed database and Google Scholar. We investigated the association between creatine supplementation and neurodegenerative illnesses by examining references.

Results: The neuroprotective effects of Cr were observed in in vitro and animal models of certain neurodegenerative diseases, while clinical trials failed to reproduce favorable outcomes.

Conclusion: Determining the optimal creatinine regime for increasing brain creatinine levels is essential for maintaining brain health and treating neurodegeneration.

References

Meyer L, Machado L, Santiago A, da-Silva W, De Felice F, Holub O . Mitochondrial creatine kinase activity prevents reactive oxygen species generation: antioxidant role of mitochondrial kinase-dependent ADP re-cycling activity. J Biol Chem. 2006; 281(49):37361-71. DOI: 10.1074/jbc.M604123200. View

Saunders N, Dziegielewska K, Mollgard K, Habgood M, Wakefield M, Lindsay H . Influx mechanisms in the embryonic and adult rat choroid plexus: a transcriptome study. Front Neurosci. 2015; 9:123. PMC: 4412010. DOI: 10.3389/fnins.2015.00123. View

Item C, Stockler-Ipsiroglu S, Stromberger C, Muhl A, Alessandri M, Bianchi M . Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet. 2001; 69(5):1127-33. PMC: 1274356. DOI: 10.1086/323765. View

Dolder M, Walzel B, Speer O, Schlattner U, Wallimann T . Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J Biol Chem. 2003; 278(20):17760-6. DOI: 10.1074/jbc.M208705200. View

Hultman E, Soderlund K, Timmons J, Cederblad G, Greenhaff P . Muscle creatine loading in men. J Appl Physiol (1985). 1996; 81(1):232-7. DOI: 10.1152/jappl.1996.81.1.232. View

Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P . Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci. 2001; 21(14):5110-20. PMC: 6762835. View

Guerrero-Ferreira R, Taylor N, Mona D, Ringler P, Lauer M, Riek R . Cryo-EM structure of alpha-synuclein fibrils. Elife. 2018; 7. PMC: 6092118. DOI: 10.7554/eLife.36402. View

Rawson E, Venezia A . Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids. 2011; 40(5):1349-62. DOI: 10.1007/s00726-011-0855-9. View

Harris R, Soderlund K, Hultman E . Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Lond). 1992; 83(3):367-74. DOI: 10.1042/cs0830367. View

10.

Bonilla D, Kreider R, Stout J, Forero D, Kerksick C, Roberts M . Metabolic Basis of Creatine in Health and Disease: A Bioinformatics-Assisted Review. Nutrients. 2021; 13(4). PMC: 8070484. DOI: 10.3390/nu13041238. View

11.

da Silva R, Clow K, Brosnan J, Brosnan M . Synthesis of guanidinoacetate and creatine from amino acids by rat pancreas. Br J Nutr. 2013; 111(4):571-7. DOI: 10.1017/S0007114513003012. View

12.

Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodriguez I, Cadena-Suarez A, Sanchez-Garibay C . Alzheimer's Disease: An Updated Overview of Its Genetics. Int J Mol Sci. 2023; 24(4). PMC: 9966419. DOI: 10.3390/ijms24043754. View

13.

Pastula D, Moore D, Bedlack R . Creatine for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2010; (6):CD005225. DOI: 10.1002/14651858.CD005225.pub2. View

14.

Tabrizi S, Blamire A, Manners D, Rajagopalan B, Styles P, Schapira A . High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study. Neurology. 2005; 64(9):1655-6. DOI: 10.1212/01.WNL.0000160388.96242.77. View

15.

Bender A, Auer D, Merl T, Reilmann R, Saemann P, Yassouridis A . Creatine supplementation lowers brain glutamate levels in Huntington's disease. J Neurol. 2005; 252(1):36-41. DOI: 10.1007/s00415-005-0595-4. View

16.

Laakso M, Hiltunen Y, Kononen M, Kivipelto M, Koivisto A, Hallikainen M . Decreased brain creatine levels in elderly apolipoprotein E epsilon 4 carriers. J Neural Transm (Vienna). 2003; 110(3):267-75. DOI: 10.1007/s00702-002-0783-7. View

17.

Quinn N, Schrag A . Huntington's disease and other choreas. J Neurol. 1998; 245(11):709-16. DOI: 10.1007/s004150050272. View

18.

Wendt S, Dedeoglu A, Speer O, Wallimann T, Beal M, Andreassen O . Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice. Free Radic Biol Med. 2002; 32(9):920-6. DOI: 10.1016/s0891-5849(02)00784-0. View

19.

Cella P, Marinello P, Borges F, Ribeiro D, Chimin P, Testa M . Creatine supplementation in Walker-256 tumor-bearing rats prevents skeletal muscle atrophy by attenuating systemic inflammation and protein degradation signaling. Eur J Nutr. 2019; 59(2):661-669. DOI: 10.1007/s00394-019-01933-6. View

20.

Dupuis L, Oudart H, Rene F, Gonzalez De Aguilar J, Loeffler J . Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004; 101(30):11159-64. PMC: 503756. DOI: 10.1073/pnas.0402026101. View